The costliest advertising mistake a new private-label beauty brand can make is letting its ads, influencer posts and before-and-after photos promise more than the product can legally be sold as, or more than its evidence can prove. Label wording usually gets checked by a regulatory person; ad copy, TikTok scripts and retouched photos often get checked by nobody. This guide covers cosmetics sold to consumers in the EU, UK, US and ASEAN. The rules differ by market, and nothing here replaces a review by someone qualified in the country where you sell. Practical first step: before your next campaign, list every claim you use and write the evidence for each one next to it.
Key takeaways
- Your ads are held to the same claim rules as your label. In the EU, Article 20 of Regulation (EC) No 1223/2009 covers advertising as well as labelling, and the US FDA judges “intended use” partly from what you say online and in promotions.
- Words that describe changing the body turn a cosmetic into a medicine. “Repairs”, “regenerates cells”, “stimulates collagen”, “treats acne” and “regrows hair” are the phrases regulators pick up most often.
- You are responsible for what influencers and customers say on your behalf. Paid posts must be labelled as ads, filters cannot exaggerate results, and fake or bought reviews are now banned outright in the US.
- Ingredient-supplier data is not evidence for your finished product. A 60% result at 3% active in a lab test does not support a claim about your serum with 0.5% active.
Who is this guide for?
This guide is for founders and marketing leads at private-label and indie beauty brands who make their product with an OEM (Original Equipment Manufacturer) or ODM (Original Design Manufacturer) and write their own marketing. It fits best right after the formula and label are signed off and just before launch ads, influencer seeding and marketplace listings go live. That is the point where the regulatory work you paid for is easiest to undo with one caption. If you have not yet built the claims into the product itself, start with our guides to clean, sustainable and science-backed claims and product testing before your first batch, then come back here.
Why do beauty ads get into trouble when the label was compliant?
Beauty ads get into trouble because the claim rules apply to every channel, but the checking usually stops at the carton. A manufacturer or regulatory consultant reviews the label because it goes into the product file. Ads, product-page copy, founder videos, influencer briefs and customer-review reposts are written later, by different people, under time pressure, and they are almost never shown to the person who checked the label.
Regulators do not draw that line. The EU Cosmetics Regulation says the labelling, making available and advertising of cosmetic products must not suggest the product has characteristics or functions it does not have, and the European Commission’s cosmetics legislation page lists Regulation (EU) No 655/2013, which sets six common criteria every claim must meet: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. In the US, the FDA’s guidance on whether a product is a cosmetic, a drug or both says intended use can be established by claims on the label, in advertising, on the internet or in other promotional materials. A drug claim in an Instagram caption can therefore make your cosmetic an unapproved drug even if the carton is clean. Advertising regulators add a second layer: the UK CAP Code (enforced by the Advertising Standards Authority, ASA) and the US Federal Trade Commission (FTC) both require that objective claims are backed by evidence before the ad runs.
The gap is widest for small brands for a simple reason: the founder is usually also the copywriter, the social media manager and the person briefing influencers. The table below maps where each mistake usually happens.
| Channel | Typical mistake | Why it fails | Safer approach |
|---|---|---|---|
| Product page / marketplace listing | Copying the ingredient supplier’s brochure claims (“boosts collagen by 60%”) | Claim describes a physiological effect and relates to the raw material, not the finished product | Claim only what your own finished-product test shows, in cosmetic wording |
| Paid social ads | “Clinically proven” with no study, or a study that tested something else | Objective claim without matching substantiation (EU 655/2013; CAP Code; FTC) | Name the study in the ad: “clinically tested on 32 volunteers over 4 weeks” |
| Influencer posts | No “#ad” label; a beauty filter on the “after” shot | Undisclosed advertising; filter exaggerates efficacy (ASA rulings, 2021) | Upfront “Ad” label; no filters on skin, hair or colour in product demos |
| Before-and-after photos | Different lighting, make-up or retouching between shots | Misleading impression of results | Same conditions, stated time point, typical result, no retouching of the treated area |
| Customer reviews | Free product for 5-star reviews; hiding negative ones; reposting “cured my eczema” | Fake or incentivised reviews (FTC rule, 2024); testimonials count as your claims | Ask for honest reviews; show all ratings; do not repost medical testimonials |
| Founder videos and live sales | Unscripted “this heals acne” or “safe for eczema” | Drug or medical claim, made by the brand itself | Give live hosts a one-page list of approved and banned phrases |
Table: original oemhallmark analysis of common failure points, built from ASA, FTC and FDA guidance cited in this article. It is a planning aid, not legal advice.
Which advertising mistakes should beauty brands avoid?
The seven mistakes below cover most of the rulings and warning letters small beauty brands receive, and each one is cheaper to prevent than to fix. They are listed roughly in order of how much damage they do.
Mistake 1: Using medicine words for a cosmetic
A cosmetic cleans, perfumes, protects, changes the appearance of, or keeps skin, hair, nails, teeth and lips in good condition. Once your copy says the product changes how the body works, it has moved into medicine territory. The US FDA gives examples of claims that make a product a drug, including claims that it will restore hair growth, reduce cellulite, treat varicose veins, increase or decrease melanin production, or regenerate cells. The ASA’s advice on physiological claims says words such as “regenerate” and “rejuvenate” applied to cells are likely to be unacceptable, and that claims to change your own collagen production are physiological claims. The EU draws its own line between cosmetics and medicines on the European Commission’s borderline products page. The fix is almost always a change of wording, not of formula, as the table below shows.
| Risky wording (reads as medicine) | Cosmetic wording that can work | Evidence you still need |
|---|---|---|
| “Stimulates collagen production” | “Skin looks visibly firmer in 4 weeks” | Instrumental or expert-graded study on the finished product |
| “Treats acne” / “heals breakouts” | “Helps reduce the look of blemishes”; “removes excess oil” | Consumer-use or expert-graded study; note that in the US acne treatment is an OTC drug category |
| “Repairs damaged skin” | “Leaves dry skin feeling smoother and more comfortable” | Consumer perception test (self-assessment questionnaire) |
| “Regrows hair” / “stops hair loss” | “Reduces breakage from brushing” | Combing or breakage test on hair tresses or panellists |
| “Removes cellulite” | “Skin looks smoother” | Before-and-after study under controlled conditions |
| “Kills 99.9% of bacteria” | “Cleanses skin” | In many markets antimicrobial claims fall under drug or biocide rules; get market-specific advice first |
| “Safe for eczema” | “Suitable for dry, sensitive-feeling skin” | Tolerance study (for example a patch test under dermatological supervision) |
Table: illustrative wording examples prepared by oemhallmark. Acceptable wording differs by market and by the overall impression of the ad, so treat these as starting points for review, not approved claims.
Mistake 2: Borrowing the ingredient supplier’s results
Ingredient suppliers publish impressive numbers: “wrinkle depth reduced 38% in 28 days”. Those studies test the raw material, usually at the supplier’s recommended dose, in the supplier’s base, on the supplier’s panel. Your formula may use a fraction of that dose alongside ingredients that change how it behaves. Regulators expect the claim to reflect the product the consumer buys, so an ad that attaches a supplier’s percentage to your serum usually cannot be supported. Supplier data is useful for choosing actives and for wording such as “formulated with [ingredient]”; it is not a finished-product efficacy claim. We cover the same problem from the formulation side in our pieces on skin-longevity claims and multifunctional claims.
Mistake 3: “Clinically proven” without a study that matches the claim
“Clinically proven”, “dermatologist tested” and “visible results in 7 days” are objective claims. Each one needs a study on the finished product that measured that exact thing. The best-known cautionary case is the FTC’s 2014 settlement with L’Oréal USA over Génifique and Youth Code ads that said the products were “clinically proven” to boost genes’ activity and give visibly younger skin in seven days. If a brand of that size can be caught by its own claims, a start-up with one small consumer test is far more exposed. The safer habit is to make the evidence visible in the claim itself: “In a 4-week consumer test, 81% of 35 women said their skin felt more hydrated.”
Mistake 4: Filters and retouching in before-and-after content
Before-and-after images are persuasive precisely because they look like proof, which is why regulators treat them strictly. In February 2021 the ASA upheld complaints against two tanning ads posted by influencers, Skinny Tan with Elly Norris and Tanologist with Cinzia Baylis-Zullo, because beauty filters exaggerated what the products could do. The ASA’s guidance on production techniques in cosmetics ads says filters are not banned in themselves, but must not mislead about the product’s efficacy. A clean before-and-after uses the same camera, lighting, angle, make-up (or none) and hairstyle in both shots, states the time between them, shows a typical rather than a best-ever result, and does not retouch the area the product treats.
Mistake 5: Treating influencer posts as the influencer’s problem
If you paid, gifted product, offered commission or have any other “material connection”, the post is your advertising. The FTC’s Disclosures 101 for social media influencers says the connection must be disclosed clearly, for example with “#ad” or “#sponsored”, and the FTC’s Endorsement Guides make clear that advertisers can be liable for what endorsers say. The ASA and CMA’s influencers’ guide says the label must be obvious and upfront, and the ASA keeps a public list of non-compliant social media influencers. Two things follow for brands. First, put the disclosure requirement in the contract. Second, give every creator a written brief with the claims they may use and the words they must not use, because an influencer who says “this cleared my rosacea” is making a medical claim for you.
Mistake 6: Buying, filtering or recycling reviews
Reviews feel like the customer’s voice, but regulators increasingly treat them as the brand’s responsibility. The FTC’s final rule banning fake reviews and testimonials, announced in August 2024, prohibits fake reviews (including AI-generated ones), buying positive or negative reviews, undisclosed insider reviews and suppressing reviews because of their rating, and it lets the FTC seek civil penalties against knowing violators. In practice that rules out “free full-size product for a 5-star review” offers. It is fine to ask every buyer for an honest review. Be careful, too, when you repost a glowing customer comment: a testimonial that says “it healed my eczema” becomes your medical claim the moment you use it in marketing.
Mistake 7: “Free-from”, “natural” and green claims that cannot be defended
“Chemical-free”, “toxin-free” and “paraben-free” used to imply that legally permitted ingredients are dangerous are the classic weak claims. The EU’s technical document on cosmetic claims, which national authorities use to apply Regulation 655/2013, includes specific guidance on “free from” and “hypoallergenic” claims, and the FDA notes on its hypoallergenic cosmetics page that there is no federal standard for the term. Environmental claims are tightening fastest. In the EU, Directive (EU) 2024/825 on empowering consumers for the green transition bans generic environmental claims such as “eco-friendly” that cannot be backed by recognised excellent environmental performance, and sustainability labels not based on a certification scheme or set by public authorities; member states must apply these rules from 27 September 2026. In the UK, the CMA’s Green Claims Code sets out how environmental claims are judged, and since April 2025 the CMA can fine businesses directly for breaking consumer law. Our sustainable beauty brand guide covers how to build green credentials you can actually prove.
What evidence should sit behind each type of ad claim?
Each type of claim needs a matching type of evidence, kept in a claims file before the ad runs, not gathered after a complaint arrives. The table below is the working version we recommend brands keep for every product. It uses the same columns for every claim type so you can see gaps at a glance.
| Claim type | Example | Evidence usually expected | Who usually provides it | Watch-out |
|---|---|---|---|---|
| Sensory / feel | “Absorbs quickly, non-greasy feel” | Consumer perception test on the finished product | Brand-commissioned test lab or OEM | Report the panel size and the percentage who agreed |
| Measurable efficacy | “+45% hydration after 1 hour” | Instrumental study (e.g. corneometer) on the finished product | Independent test lab | Number must match the study’s time point and conditions |
| Visible result over time | “Brighter-looking skin in 4 weeks” | Controlled-use study with expert grading or imaging | Independent test lab | Before-and-after images must come from this study |
| Tolerance / skin type | “Dermatologist tested”, “for sensitive skin” | Patch test and/or in-use tolerance study under dermatological supervision | Test lab; sometimes arranged by the OEM | “Tested” is not “approved” or “recommended” |
| Ingredient presence | “With 5% niacinamide” | Formula record and certificate of analysis | OEM | Percentage must match the approved formula |
| “Free from” | “Fragrance-free” | Full formula disclosure, including raw-material sub-components | OEM and raw-material suppliers | Must not denigrate permitted ingredients |
| Environmental | “Carton made from 80% recycled board” | Supplier certificate or recognised certification | Packaging supplier | Specific and measurable, never generic (“eco”) |
| Comparative / superlative | “No.1 vitamin C serum on Shopee” | Dated sales or ranking data for a defined market and period | Marketplace data, audited | State the basis, market and date next to the claim |
Table: original oemhallmark claims-file template. The evidence level regulators expect rises with how strong, specific and health-related the claim sounds.
Much of the product-level evidence is set before launch, which is why it pays to agree the claims list with your manufacturer while the formula is still being finalised. Your OEM can usually supply the formula record, certificates of analysis and, for EU and UK sales, the Cosmetic Product Safety Report (CPSR); see our CPSR explainer. Efficacy studies are normally the brand’s job and budget. If you plan to sell in several countries, check early whether your claims survive each market’s rules; our guide to expanding into the EU, UK and US walks through the regulatory side. In ASEAN, claims are judged against the ASEAN Cosmetic Directive and its claims guideline, which the Health Sciences Authority (HSA) of Singapore summarises; China’s NMPA goes further and requires brands to publish a summary of the evidence behind efficacy claims.
How do you check an ad before it goes live?
A five-minute check against a written claims file catches most problems before they are published. Run these steps on every new ad, product page, influencer brief and live-sale script:
- List every claim. Include implied claims from images, emojis, product names (“Acne Rescue”) and hashtags (“#eczemarelief”).
- Screen for medicine words. Treat, cure, heal, repair, regenerate, stimulate, prevent disease, hair regrowth, anti-bacterial.
- Match each objective claim to a finished-product study in your claims file, with the same number, time point and panel.
- Check images. No filters or retouching on the treated area; before-and-after shots from the same study, under the same conditions.
- Check disclosure. Paid, gifted or affiliate content labelled “Ad” at the start, not buried in hashtags.
- Check the market. A claim that is acceptable in one country may not be in another; ads served across borders need to pass in every target market.
- Keep a record. Save the approved version, the date and who approved it, so you can respond quickly if a complaint or a customer adverse-reaction report arrives.
If you are still choosing a manufacturer, ask during vetting whether they can support claims testing and supply full formula disclosure for “free from” claims. You can compare factories and their stated capabilities in the oemhallmark manufacturer directory.
Frequently asked questions
Can I use my ingredient supplier’s clinical results in my ads?
Usually not as a claim about your product. Supplier studies test the raw material at a set dose in a set base, so the result does not transfer to your formula. You can say the product is “formulated with” the ingredient and describe what it is. For a numbered result, commission a study on your finished product and quote that instead.
Who is responsible if an influencer makes a medical claim about my product?
Both of you, in practice. The FTC says advertisers can be liable for what paid endorsers say, and the UK ASA can rule against both the brand and the influencer. Protect yourself with a written brief listing approved and banned claims, a disclosure clause in the contract, and a right to have non-compliant posts corrected or removed.
Are before-and-after photos allowed for cosmetics?
Yes, if they are honest. Use images from a real study or a documented user, with the same lighting, angle and make-up in both shots, a stated time period and no retouching or filter on the treated area. Show a typical result, not the single best one. The ASA upheld two complaints in 2021 where filters exaggerated tanning results.
What does “dermatologist tested” actually require?
It requires a real test carried out or supervised by a dermatologist on the finished product, usually a patch test or an in-use tolerance study, and a report you can produce on request. It does not mean the product is approved or recommended by dermatologists. “Dermatologist recommended” is a different, stronger claim that needs its own evidence, such as a survey of dermatologists.
Do these rules apply if I only sell on TikTok Shop, Shopee or Amazon?
Yes. Advertising and cosmetics rules follow where the consumer is, not the platform, and marketplaces also have their own policies and can remove listings. If a marketplace ad reaches buyers in several countries, the claim needs to pass in each of them. Keep your listings consistent with your label and your claims file.
What happens if a regulator rules against my ad?
Consequences range from a published ruling and an order to withdraw the ad to fines and product action. The ASA publishes rulings and can refer repeat offenders to Trading Standards; the FTC can seek civil penalties for fake reviews; the FDA can treat a product with drug claims as an unapproved drug. For a small brand the reputational cost of a public ruling is often the biggest hit.
Sources and limitations
This article draws on primary guidance checked on 22 September 2026: the European Commission’s cosmetics legislation and borderline-products pages (Regulation (EC) No 1223/2009, Regulation (EU) No 655/2013); the US FDA’s “Is it a cosmetic, a drug, or both?” and hypoallergenic cosmetics pages; the FTC’s Endorsement Guides resources, Disclosures 101 for social media influencers, the 2014 L’Oréal USA settlement and the August 2024 final rule on fake reviews and testimonials; the UK CAP Code, ASA advice on physiological claims and production techniques, the ASA rulings on Skinny Tan and Tanologist (February 2021), the ASA/CMA influencers’ guide and the CMA Green Claims Code; and HSA Singapore’s ASEAN Cosmetic Directive page. Directive (EU) 2024/825 and the EU technical document on cosmetic claims are cited by name because the official EUR-Lex and Commission document pages could not be reliably reached for linking. The wording and evidence tables are illustrative planning aids prepared by oemhallmark, not approved claims. Whether a particular claim is acceptable depends on the market, the product and the overall impression of the ad; check with a qualified regulatory or legal adviser in each market before launch.
This article is general information for beauty brand owners and is not legal or regulatory advice. Rules change; confirm current requirements with the relevant authority before you publish advertising.